IL-2 | IFN-gamma | IL-17A | ||||
Control subjects | OA | Control subjects | OA | Control subjects | OA | |
Unstimulated | 0 (0 - 32.5) | 31.6 (0 - 61.3) | 0 (0 - 38.1) | 2.2 (0 - 48.4) | 0 (0 - 0) | 0 (0 - 0) |
PHA stimulation | 314.09 (28.5 - 1999.2) | 151.1 (32.5 - 1400.3) | 1768.7 (0 - 3517.1) | 351.5 (33.3 - 1862.7) | 0 (0 - 341.3) | 176.4 (0 - 943.3) |
PHA stimulation + CSA | 135.8 (33.0 - 711.7) | 77.7 (0 - 1159.2) | 1292.0 (4.8 - 3634.9) | 196.3 (8.64 - 1862.7) | 0 (0 - 2.0) | 0 (0 - 206.5) |
PHA stimulation + abatacept | 121.4 (0 - 1514.8) | 140.3 (36.3 - 1535.7) | 643.9 (0 - 4255.4) | 362.0 (27.6 - 1594.7) | 0 (0 - 167.7) | 204.2 (0 - 768.3) |